Economic Atlas
Companies/Insmed Incorporated
Company profile

Insmed Incorporated

NASDAQ: INSM · Healthcare · Biotechnology
PublicHQ Bridgewater, NJCIK 0001104506Reports USD
#196 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
66B
Revenue TTM
$819.6M
Rev growth YoY (TTM)
+115.1%
Net income (FY)
-$1.3B
Employees
1,664
as of 2026-08-05
Market cap
$21.4B
as of 2026-08-05

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$606.4M$606.4M2025
Net income-$1.3B-$1.3B2025
Operating income-$1.2B-$1.2B2025
Total assets$2.3B$2.3B2025
Liabilities$1.5B$1.5B2025
Equity$739.0M$739.0M2025

Revenue trend

FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Reportable100%
By geography
UNITED STATES75%
Non-US25%
The read

What is Insmed Incorporated’s revenue?

Insmed Incorporated booked $606.4M in FY2025 revenue, growing 67% year over year — faster than most Healthcare companies we track, at a -210.5% net margin.

Peers · Healthcare
Axsome Therapeutics, Inc.59CTG Therapeutics, Inc.72BOPKO Health, Inc.74BTransMedics Group, Inc.77B+UFP Technologies, Inc.80B+Veradigm Inc.——
Key facts
CEOWilliam H. Lewis
SectorHealthcare
IndustryBiotechnology
HeadquartersBridgewater, NJ
ExchangeNASDAQ: INSM
Employees1,664
IPO date2000-06-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.